Reveals selective cytotoxic effects of GO–ZnO heterostructures on colon cancer cells, suggesting promising biomedical applications.
A novel photo-induced, additive-minimized strategy was developed for the synthesis of graphene oxide–zinc oxide (GO–ZnO) heterostructures under mild reaction conditions. Unlike conventional hydrothermal or chemically assisted approaches, the present method utilizes light-driven nucleation and growth to achieve controlled interfacial integration of nanocrystalline ZnO (∼17–24 nm) on ultrathin GO sheets without requiring complex reagents or harsh processing conditions. Structural analyses using XRD, FTIR, and HRTEM confirmed the successful formation of a well-dispersed GO–ZnO heterostructure with strong interfacial interaction between ZnO nanoparticles and oxygen-functionalized GO layers. The synthesized nanocomposite exhibited selective cytotoxic behavior toward HCT116 colon cancer cells, showing concentration-dependent reduction in cell viability with an IC₅₀ value of ∼69.68 µg mL⁻¹ , while maintaining high biocompatibility (>93% viability) toward HEK293 normal cells even at 200 µg mL⁻¹ . The enhanced selective response is attributed to the synergistic interfacial effects of the GO–ZnO heterostructure, which may promote reactive oxygen species (ROS)-related cellular stress in cancer cells. This work demonstrates a simple and energy-efficient light-assisted route for constructing GO–ZnO heterostructures with selective biological activity and highlights their potential for future biomedical applications.
No takes yet. Share an insight, caveat, or question.
Ganeshan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: